Shuangtengbitong tincture (
STBT), a clinical prescription from the Fujian University of
Traditional Chinese Medicine (TCM) Affiliated People's Hospital (Fuzhou, China), has been used in the treatment of
rheumatoid arthritis (RA) for ~10 years. The aim of the current study was to confirm the anti-RA effect of
STBT and to evaluate the potential mechanisms underlying
collagen-induced arthritis (CIA) in rats. CIA model Wistar rats were induced with bovine
type II collagen. The rats were immunized with CIA and were treated with
STBT (0.5 and 2 ml/injection) and votalin (~1 cm/injection) continuously for ~1 month. Following treatment, the pathological sections of CIA rat joints were observed by
hematoxylin and
eosin staining, expression of toll-like receptor-4 (TLR4),
myeloid differentiation factor 88 (MyD88) and nuclear
transcription factor-κB (NF-κB) were investigated by western blot analysis and reverse transcription-polymerase chain reaction (RT-PCR) analysis. Following treatment,
STBT significantly suppressed paw swelling (P<0.05) compared with the model group and increased
body weight.
STBT also reversed pathological changes, STBT‑treated rats showed a significant improvement of synovial
hyperplasia, inflammatory infiltration, and cartilage and bone destruction. The levels of
protein and
mRNA expression of TLR4, MyD88 and NF-κB were markedly suppressed in the synovial tissue of STBT‑ and votalin-treated rats. In addition,
STBT showed marked inhibition of the levels of
protein and
mRNA expression of TLR4, MyD88 and NF-κB at an
STBT volume ranging between 1 and 4 ml/day, indicating that the inhibition was volume dependent. These results show that
STBT inhibits CIA and may be correlated with TLR4, MyD88 and NF-κB expression.